Literature DB >> 7847347

The link between hypertension and nephrosclerosis.

B I Freedman1, S S Iskandar, R G Appel.   

Abstract

Nephrosclerosis is literally defined as hardening of the kidneys (Greek derivation: nephros, kidney; sklerosis, hardening). It is the result of scarring or replacement of the normal renal parenchyma by dense collagenous tissue. In practice, nephrosclerosis refers to diseases with predominant pathologic changes occurring in the preglomerular microvasculature and secondarily involving the glomeruli and interstitium. The relationship between mild to moderate hypertension and either nephrosclerosis or end-stage renal disease (ESRD) remains circumstantial, although these syndromes have long been associated in the medical literature. Nephrologists credit hypertension as the etiology of nephrosclerosis in 25% of patients initiating Medicare-supported renal replacement therapy, even though other processes may cause similar renal pathologic findings. Strikingly, serum creatinine values infrequently increase in patients with long-standing mild to moderate hypertension. Patients classified as having hypertensive ESRD typically present with advanced disease, making the processes that initiated the renal disease difficult to detect. Nephrologists are twice as likely to label an African-American patient as having hypertensive nephrosclerosis, compared with a white patient, when presented with identical clinical histories. This review proposes that many patients classified as having hypertensive nephrosclerosis actually have intrinsic renal parenchymal diseases, renal artery stenosis, unrecognized episodes of accelerated hypertension, or a primary renal microvascular disease. The familial clustering of ESRD attributed to hypertension in African-Americans and the identification of genes associated with renal injury in animals support the concept that inherited factors may predispose to renal failure. African-American families often have members with ESRD from disparate etiologies, including hypertensive ESRD. This suggests that common mechanisms, be they inherited or environmental, underlie the development of progressive renal failure in diverse forms of nephropathy. Identification of the mechanisms producing susceptibility to progressive renal disease would support the concept that mild to moderate elevations in blood pressure per se are uncommon causes of nephrosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847347     DOI: 10.1016/0272-6386(95)90001-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  51 in total

1.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

2.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

3.  Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.

Authors:  Isai Gopalakrishnan; Samy S Iskandar; Pirouz Daeihagh; Jasmin Divers; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Michael V Rocco; Barry I Freedman
Journal:  Hum Pathol       Date:  2010-11-13       Impact factor: 3.466

Review 4.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

5.  Hypertension and reduced renal function in an 83-year-old patient.

Authors:  Andrea Ungar; Lorella Lambertucci; Chiara Agresti; Riccardo Pini; Maria Boddi; Maria Consuelo Valentini; Gianfranco Parati; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

6.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

7.  Complement factor H gene associations with end-stage kidney disease in African Americans.

Authors:  Jason A Bonomo; Nicholette D Palmer; Pamela J Hicks; Janice P Lea; Mark D Okusa; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2014-02-28       Impact factor: 5.992

8.  Human nephrosclerosis triggers a hypoxia-related glomerulopathy.

Authors:  Matthias A Neusser; Maja T Lindenmeyer; Anton G Moll; Stephan Segerer; Ilka Edenhofer; Kontheari Sen; Daniel P Stiehl; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff; Clemens D Cohen
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  African American hypertensive nephropathy maps to a new locus on chromosome 9q31-q32.

Authors:  Ki Wha Chung; Robert E Ferrell; Demetrius Ellis; Michael Barmada; Michael Moritz; David N Finegold; Ronald Jaffe; Abhay Vats
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

Review 10.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.